Charles River pens Takeda early-stage drugs deal

Charles River pens Takeda early-stage drugs deal

Source: 
Fierce Biotech
snippet: 

At the annual J.P. Morgan Healthcare Conference, major CRO Charles River Laboratories and Japanese Big Pharma Takeda announced a new preclinical tie-up.